Mosaic Health Solutions becomes Delaware C-corp ahead of August clinical pilot

Mosaic Health Solutions has incorporated as a Delaware C-corporation as the healthcare technology startup prepares for its first clinical pilot in August 2026. The move formalizes the company’s structure for planned growth and future investment as it develops AI tools aimed at reducing medication harm for older adults.

Why it matters: - Mosaic Health Solutions is trying to reduce medication-related harm in older adults, a group especially exposed to prescribing cascades, anticholinergic burden, and fall risk. - The new corporate structure gives the startup a formal base for clinical work, pilot partnerships and future fundraising.

What happened: - Mosaic Health Solutions incorporated as a Delaware C-corporation on July 9, 2026. - The company is a healthcare technology startup founded by Nihit Gurram. - Mosaic Health Solutions builds AI-powered clinical decision support for medication safety in older adults. - The company’s first clinical pilot is scheduled for August 2026.

The details: - Mosaic Health Solutions develops transparent, explainable tools that help clinicians identify medication-related risk before harm occurs. - The company translates established clinical criteria into point-of-care support for prescribing decisions. - Mosaic Health Solutions says its approach is designed to surface risk in aging patients on complex medication regimens. - Gurram said the Delaware C-corp structure signals to pilot partners, advisors and investors that the company is building with serious healthcare governance. - Gurram said the mission remains focused on technology designed specifically for patients most exposed to medication harm. - The company has established a board advisory team with clinical and business development expertise. - Mosaic Health Solutions launched its corporate website at mosaichealthsolutions.io. - The company has scheduled its minimum viable product for the August 2026 clinical pilot. - Gurram was selected as a semi-finalist for the Nucleate SF Activator as a lead inventor. - Gurram will complete his master's degree in health informatics at the University of South Florida in August 2026. - Mosaic Health Solutions says its mission is to make preventive medication safety practical for clinicians and families.

Between the lines: - The incorporation suggests Mosaic Health Solutions is moving from startup formation toward clinical validation and a more traditional investor-ready structure. - The company’s “glass-box” AI framing is a response to clinician concerns about opaque decision tools in healthcare. - The focus on explainability matters because medication guidance in older adults affects daily prescribing decisions, not just abstract model performance.

What's next: - Mosaic Health Solutions will begin its first clinical pilot in August 2026. - The company is preparing to test whether its medication-safety tools fit real clinical workflows. - Further progress will likely depend on pilot results, advisor support and outside investment.

The bottom line: - Mosaic Health Solutions is formalizing its business at the same time it moves toward real-world testing of AI tools meant to make older adults safer on complex medication regimens.